| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC4136 | |||||||||||||||||||||||
| Submitter : | Mr. David Wehrle | Date & Time: | 12/22/2006 10:12:58 | |||||||||||||||||||||
| Organization : | Mr. David Wehrle | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Dear Sir/Madam:
I strongly oppose the use of aborted fetal cell lines for the development of vaccines. I urge the pharmaceutical industry and other researchers to use ethical cell lines, such as bacteria, insect cell lines, and chick embryo, in developing vaccines. Sincerely, David Wehrle | ||||||||||||||||||||||||